Weight Loss + GLP's

A dual GIP and GLP-1 receptor agonist studied in clinical research for its effects on appetite signaling, glycemic control, and weight management.

What to expect: Hunger usually fades, portions get smaller, and weight comes off slowly over weeks, with some people getting mild nausea when the dose increases.

A long-acting amylin analogue investigated in clinical research for appetite regulation and weight management, often studied alongside GLP-1 agonists.

What to expect: Meals feel satisfying sooner, snacking drops, and weight loss is gradual, with possible mild nausea while your stomach adjusts.